Overview

A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension

Status:
Not yet recruiting
Trial end date:
2025-03-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of macitentan on hemodynamic measures at Week 24 in pediatric populations.
Phase:
Phase 3
Details
Lead Sponsor:
Janssen Pharmaceutical K.K.
Treatments:
Macitentan